| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |